November 18th, 2024: Ratio Enters License and Collaboration …
5 days ago · Ratio to to receive upfront, and potential milestones and tiered royalty payments. BOSTON, November 18, 2024 /PRNewswire/ — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for …
OFF
Novartis Inks $745M Radiopharma Partnership With Ratio …
6 days from now
4 days ago · November 18, 2024. 2:47 pm. Credit: Getty Images / Gabriel Monnet. Novartis secured a $745 million partnership with radiopharmaceutical biotech Ratio Therapeutics to …
mmm-online.com
OFF
Novartis Taps Ratio For $745M Radiopharmaceutical Pact
6 days from now
Nov 15, 2024 · Novartis Licensing deals Ratio Therapeutics radiopharmaceuticals. Novartis is adding another radiopharmaceutical program to its collection, penning a deal worth $745 …
fiercebiotech.com
OFF
Ratio Therapeutics Launches To Discover And Drive Early
6 days from now
Jun 10, 2022 · Company Emerges from Stealth Mode with More Than $20 Million in Seed Financing and Fully Funded Development Alliances with Bayer and Lantheus. BOSTON, June …
biospace.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To
6 days from now
Jan 17, 2024 · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch. BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio …
biospace.com
OFF
Ratio Raises $20m To Build On Its Radiopharma Ambitions
6 days from now
2 days ago · Ratio Therapeutics. Boston-based biotech Ratio Therapeutics has doubled its funding at a stroke with a $20 million Series A that will be used to usher its targeted …
pharmaphorum.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To …
6 days from now
BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …
yahoo.com
OFF
Ratio Therapeutics Secures Funds For Cancer Radiotherapies
6 days from now
Jan 18, 2024 · Ratio Therapeutics has secured $50m in a Series B financing round, a significant move aimed at advancing targeted radiotherapies for cancer treatment. The funding, which …
pharmaceutical-technology.com
OFF
Ratio Therapeutics Announces $20M Series A Financing To …
6 days from now
BOSTON, Feb. 1, 2023 /PRNewswire/ -- Ratio Therapeutics Inc., a pharmaceutical company specializing in the development of targeted radiotherapeutics for the treatment of cancer, …
prnewswire.com
OFF
Novartis Acquires Kate Therapeutics To Advance Gene Therapies
6 days from now
1 day ago · Novartis has announced the acquisition of San Diego-based Kate Therapeutics in a deal valued at $1.1bn, enhancing its portfolio of gene therapies for inherited neuromuscular …
pharmaceutical-technology.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
13 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …
yahoo.com
OFF
Spero Therapeutics (SPRO) Earnings Date And Reports 2024
6 days from now
1 day ago · Spero Therapeutics (NASDAQ:SPRO) has a recorded net income of $22.81 million. SPRO has generated $0.07 earnings per share over the last four quarters. What is Spero …
marketbeat.com
FAQs about November 18th, 2024: Ratio Enters License and Collaboration … Coupon?
What does ratio Therapeutics do?
What are ratio Therapeutics' proprietary R&D platforms?
What are Ratio's R&D platforms?
Where is Ratio Therapeutics based?
What are ratio's proprietary R&D platforms?
Is ratio pursuing a partnership with other companies?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
